GLENMARK LIFE SCIENCES
|
GLENMARK LIFE SCIENCES Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹14 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹1.96 Cr | ₹1.96 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹10.00 |
Share Warrants & Outstandings | ₹11 Cr | ₹6.68 Cr | ₹3.50 Cr | - | - |
Total Reserves | ₹2,297 Cr | ₹2,107 Cr | ₹2,026 Cr | ₹751 Cr | ₹400 Cr |
Securities Premium | ₹1,005 Cr | ₹1,005 Cr | ₹1,005 Cr | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹1,292 Cr | ₹1,102 Cr | ₹1,021 Cr | ₹751 Cr | ₹400 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹2,297 Cr | ₹2,107 Cr | ₹2,026 Cr | ₹751 Cr | ₹400 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,332 Cr | ₹2,138 Cr | ₹2,054 Cr | ₹753 Cr | ₹402 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹49 Cr | ₹42 Cr | ₹31 Cr | ₹23 Cr | ₹16 Cr |
Deferred Tax Assets | ₹4.55 Cr | ₹1.81 Cr | ₹1.07 Cr | ₹2.03 Cr | ₹0.13 Cr |
Deferred Tax Liability | ₹53 Cr | ₹44 Cr | ₹33 Cr | ₹25 Cr | ₹17 Cr |
Other Long Term Liabilities | ₹15 Cr | ₹17 Cr | ₹1.20 Cr | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹693 Cr | ₹7.87 Cr | - | - | - |
Total Non-Current Liabilities | ₹757 Cr | ₹67 Cr | ₹33 Cr | ₹23 Cr | ₹16 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹369 Cr | ₹427 Cr | ₹308 Cr | ₹221 Cr | ₹201 Cr |
Sundry Creditors | ₹369 Cr | ₹427 Cr | ₹308 Cr | ₹221 Cr | ₹201 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹58 Cr | ₹55 Cr | ₹50 Cr | ₹967 Cr | ₹1,084 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹5.26 Cr | ₹1.94 Cr | ₹1.13 Cr | ₹7.29 Cr | ₹5.41 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹53 Cr | ₹53 Cr | ₹49 Cr | ₹959 Cr | ₹1,079 Cr |
Short Term Borrowings | - | - | - | - | ₹0.02 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | - | ₹0.02 Cr |
Short Term Provisions | ₹12 Cr | ₹533 Cr | ₹389 Cr | ₹257 Cr | ₹22 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹525 Cr | ₹375 Cr | ₹237 Cr | ₹8.36 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹12 Cr | ₹7.67 Cr | ₹14 Cr | ₹20 Cr | ₹14 Cr |
Total Current Liabilities | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr | ₹1,307 Cr |
Total Liabilities | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr | ₹1,726 Cr |
ASSETS | |||||
Gross Block | ₹1,012 Cr | ₹936 Cr | ₹706 Cr | ₹652 Cr | ₹595 Cr |
Less: Accumulated Depreciation | ₹207 Cr | ₹156 Cr | ₹116 Cr | ₹79 Cr | ₹49 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹805 Cr | ₹781 Cr | ₹590 Cr | ₹573 Cr | ₹546 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹101 Cr | ₹49 Cr | ₹92 Cr | ₹14 Cr | ₹11 Cr |
Non Current Investments | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Long Term Investment | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Long Term Loans & Advances | ₹701 Cr | ₹9.49 Cr | ₹20 Cr | ₹11 Cr | ₹8.44 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹1,612 Cr | ₹852 Cr | ₹706 Cr | ₹598 Cr | ₹565 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹667 Cr | ₹604 Cr | ₹516 Cr | ₹513 Cr | ₹413 Cr |
Raw Materials | ₹174 Cr | ₹168 Cr | ₹165 Cr | ₹117 Cr | ₹86 Cr |
Work-in Progress | ₹408 Cr | ₹371 Cr | ₹310 Cr | ₹342 Cr | ₹272 Cr |
Finished Goods | ₹68 Cr | ₹49 Cr | ₹25 Cr | ₹35 Cr | ₹35 Cr |
Packing Materials | ₹1.29 Cr | ₹1.21 Cr | ₹1.25 Cr | ₹1.15 Cr | ₹1.06 Cr |
Stores  and Spare | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹18 Cr | ₹19 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹765 Cr | ₹807 Cr | ₹673 Cr | ₹620 Cr | ₹639 Cr |
Debtors more than Six months | ₹25 Cr | ₹4.16 Cr | ₹0.59 Cr | ₹64 Cr | ₹28 Cr |
Debtors Others | ₹741 Cr | ₹803 Cr | ₹673 Cr | ₹556 Cr | ₹610 Cr |
Cash and Bank | ₹302 Cr | ₹309 Cr | ₹512 Cr | ₹116 Cr | ₹10.00 Cr |
Cash in hand | ₹0.04 Cr | ₹0.09 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr |
Balances at Bank | ₹302 Cr | ₹309 Cr | ₹512 Cr | ₹115 Cr | ₹9.89 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹92 Cr | ₹72 Cr | ₹5.96 Cr | ₹26 Cr | ₹21 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.81 Cr | ₹0.14 Cr | ₹0.16 Cr | ₹0.94 Cr | ₹0.34 Cr |
Other current_assets | ₹91 Cr | ₹72 Cr | ₹5.79 Cr | ₹25 Cr | ₹21 Cr |
Short Term Loans and Advances | ₹91 Cr | ₹577 Cr | ₹420 Cr | ₹348 Cr | ₹78 Cr |
Advances recoverable in cash or in kind | ₹15 Cr | ₹18 Cr | ₹37 Cr | ₹77 Cr | ₹65 Cr |
Advance income tax and TDS | - | ₹518 Cr | ₹363 Cr | ₹223 Cr | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹76 Cr | ₹41 Cr | ₹19 Cr | ₹47 Cr | ₹13 Cr |
Total Current Assets | ₹1,916 Cr | ₹2,369 Cr | ₹2,127 Cr | ₹1,623 Cr | ₹1,160 Cr |
Net Current Assets (Including Current Investments) | ₹1,477 Cr | ₹1,354 Cr | ₹1,381 Cr | ₹178 Cr | ₹-147 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr | ₹1,726 Cr |
Contingent Liabilities | ₹4.82 Cr | ₹2.22 Cr | ₹2.22 Cr | ₹2.22 Cr | ₹2.22 Cr |
Total Debt | - | - | - | - | ₹0.02 Cr |
Book Value | - | 173.97 | 167.38 | 768.11 | 2,049.45 |
Adjusted Book Value | 189.45 | 173.97 | 167.38 | 69.83 | 37.26 |
Compare Balance Sheet of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,067.1 Cr | -1.6% | 2.6% | 74.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -1.6% |
2.6% |
74.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses